Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.

Biotechnology

Indapta Therapeutics

Mark W. Frohlich

Moya Daniels

Ronald Martell

Robert Sikorski

Austin Bigley

The leadership team at Indapta Therapeutics has a wealth of experience in the biotech industry. The team's founder has experience as a VP of Intellectual Property/Gov't Affairs and as a CEO, Chairman, and Inventor. The team's Operations Management Consultant has experience in management consulting. The team's Executive Vice President and General Counsel has experience in the biotech industry.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Indapta Therapeutics

Board of Directors

CEO and Executive Team